Abstract
Purpose: To evaluate the clinical curative effect and safety of plasmakinetic enucleation of the prostate (PKEP) in different stages versus plasmakinetic resection of the prostate (PKRP) in the treatment for benign prostate hyperplasia (BPH). Methods: Clinical data of 171 hospitalized patients who suffered from BPH undergoing PKEP or PKRP were collected. All patients were separated into PKEP1 group (n = 44, between July 2018 to June 2019), PKRP group (n = 72, between July 2018 to June 2020), and PKEP2 group (n = 55, between July 2019 to June 2020). General preoperative clinical data, perioperative and postoperative results, and complications were recorded and analyzed among the 3 groups. Results: The hemoglobin change in the PKEP1 and PKEP2 were more slightly than that in the PKRP (P > 0.05). Compared with PKRP, more prostate weight was removed in PKEP1 and PKEP2 (P < 0.05). The operation time of PKEP2 was reduced significantly (P < 0.05), compared with PKEP1 and PKRP. We further found the ratio of operation time to prostate volume(çrsç = 0.630, P < 0.001), and the ratio of operation time to enucleation weight(çrsç = 0.540, P < 0.001) were both decreased with the increase of the number of surgical cases. Compared with preoperative results, postoperative 3-month IPSS, QOL and RUV decreased, while Qmax increased in the 3 groups (P < 0.05). Conclusion: In terms of surgical safety and efficacy, skilled PKEP was comparable with PKRP, in addition it is superior to PKRP in operation time and enucleation weight.
Efficacy and Safety of the Doxazosin Gastrointestinal Therapeutic System for the Treatment of Benign Prostate Hyperplasia
